Literature DB >> 24102264

Activated platelet chemiluminescence and presence of CD45+ platelets in patients with acute myocardial infarction.

Zufar Gabbasov1, Oxana Ivanova, Victor Kogan-Yasny, Evgeniya Ryzhkova, Olga Saburova, Inna Vorobyeva, Elena Vasilieva.   

Abstract

It has been found that in 15% of acute myocardial infarction patients' platelets generate reactive oxygen species that can be detected with luminol-enhanced chemiluminescence of platelet-rich plasma within 8-10 days after acute myocardial infarction. This increase in generate reactive oxygen species production coincides with the emergence of CD45(+) platelets. The ability of platelets to carry surface leukocyte antigen implies their participation in exchange of specific proteins in the course of acute myocardial infarction. Future studies of CD45(+) platelets in peripheral blood of acute myocardial infarction patients in association with generate reactive oxygen species production may provide a new insight into the complex mechanisms of cell-cell interactions associated with acute myocardial infarction.

Entities:  

Keywords:  Acute myocardial infarction; CD45; chemiluminescence; platelets

Mesh:

Substances:

Year:  2013        PMID: 24102264     DOI: 10.3109/09537104.2013.829211

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  2 in total

1.  Blood level of CD45+ platelets and development of restenosis after drug-eluting stent implantation in patients with stable coronary artery disease.

Authors:  Zufar Gabbasov; Sergey Kozlov; Svetlana Byazrova; Olga Saburova; Ivan Melnikov; Martin Caprnda; Eduard Curilla; Ludovit Gaspar; Peter Kruzliak; Vladimir Smirnov
Journal:  Wien Klin Wochenschr       Date:  2016-09-08       Impact factor: 1.704

2.  Platelet subpopulation bearing leukocyte specific antigen and tissue factor.

Authors:  Z A Gabbasov; O S Saburova; O A Antonova; N V Golubeva; S G Khaspekova; O N Shustova; I T Zyuryaev; M Ya Ruda; A V Mazurov
Journal:  Dokl Biochem Biophys       Date:  2017-01-06       Impact factor: 0.788

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.